California State Teachers Retirement System Albireo Pharma, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $11,616 - $15,338	645 Added 2.94%	22,599 $488,000
Q3 2022 Nov 18, 2022	SELL	$16.32 - $26.37 $1,746 - $2,821	-107 Reduced 0.49%	21,954 $425,000
Q2 2022 Aug 15, 2022	BUY	$18.54 - $37.29 $9,677 - $19,465	522 Added 2.42%	22,061 $438,000
Q1 2022 May 16, 2022	SELL	$23.94 - $33.74 $33,492 - $47,202	-1,399 Reduced 6.1%	21,539 $643,000
Q4 2021 Feb 15, 2022	BUY	$21.19 - $31.29 $26,657 - $39,362	1,258 Added 5.8%	22,938 $534,000
Q3 2021 Nov 15, 2021	SELL	$27.36 - $35.98 $44,268 - $58,215	-1,618 Reduced 6.94%	21,680 $676,000
Q2 2021 Aug 16, 2021	SELL	$28.9 - $36.87 $64,822 - $82,699	-2,243 Reduced 8.78%	23,298 $820,000
Q1 2021 May 18, 2021	SELL	$32.03 - $42.85 $2,466 - $3,299	-77 Reduced 0.3%	25,541 $900,000
Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $176,262 - $235,463	5,585 Added 27.88%	25,618 $961,000
Q3 2020 Nov 17, 2020	BUY	$23.19 - $41.61 $14,841 - $26,630	640 Added 3.3%	20,033 $669,000
Q1 2020 May 13, 2020	BUY	$11.67 - $27.23 $28,439 - $66,359	2,437 Added 14.37%	19,393 $317,000
Q3 2019 Nov 15, 2019	BUY	$20.0 - $31.88 $21,140 - $33,697	1,057 Added 6.65%	16,956 $339,000
Q2 2019 Aug 14, 2019	BUY	$30.67 - $37.86 $50,084 - $61,825	1,633 Added 11.45%	15,899 $513,000
Q4 2018 Feb 13, 2019	BUY	$20.9 - $32.57 $4,890 - $7,621	234 Added 1.67%	14,266 $350,000
Q3 2018 Nov 14, 2018	BUY	$29.29 - $36.87 $2,694 - $3,392	92 Added 0.66%	14,032 $462,000
Q2 2018 Aug 14, 2018	BUY	$28.9 - $37.31 $402,866 - $520,101	13,940 New	13,940 $495,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account